Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians

Archives of Internal Medicine

Volumn 157, Issue 22, 1997, Pages 2570-2576

  Ayanian, John Z ^a,b   Guadagnoli, Edward ^b   McNeil, Barbara J ^b   Cleary, Paul D ^b  

^a Division of General Medicine   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; COMPETENCE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FIBRINOLYTIC THERAPY; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030663988     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.1997.00440430048006     Document Type: Article

References (36)

1. Gaus CR, Clancy CM. Research at the interface of primary and specialty care. JAMA. 1995;274:1419.
2. Fihn SD. Physician specialty, systems of health care, and patient outcomes. JAMA. 1995;274:1473-1474.
3. Kassirer JP. Access to specialty care. N Engl J Med. 1994;331:1151-1153.
4. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994;331:1136-1142.
5. Greenfield S, Nelson EC, Zubkoff M, et al. Variations in resource utilization among medical specialties and systems of care: results from the Medical Outcomes Study. JAMA. 1992;267:1624-1630.
6. Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties: results from the Medical Outcomes Study. JAMA. 1995;274:1436-1444.
7. Schreiber TL, Elkhatib A, Grines CL, O'Neill WW. Cardiologist versus internist management of patients with unstable angina: treatment patterns and out-comes. J Am Coll Cardiol. 1995;26:577-582.
8. Focus on Heart Attack in Pennsylvania: The Technical Report - 1993. Harrisburg: Pennsylvania Health Care Cost Containment Council; 1996.
9. Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335:1880-1887.
10. Division of Quality Control Management, American Hospital Association. Inter- national Classification of Diseases, Ninth Revision, Clinical Modification. Chicago, III: American Hospital Publishing Inc; 1989.
11. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 1995;333:573-578.
12. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-1514.
13. Normand SL, Glickman ME, Sharma RG, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: results from the Cooperative Cardiovascular Project. JAMA. 1996;275:1322-1328.
14. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? analysis using instrumental variables. JAMA. 1994;272:859-866.
15. Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications. New York, NY: John Wiley & Sons Inc; 1991.
16. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995;311:793-796.
17. Brook RH, McGlynn EA, Cleary PD. Measuring quality of care. N Engl J Med. 1996;335:966-969.
18. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Beta blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med. 1992;93:605-610.
19. Pashos CL, Normand SL, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988-1992. J Am Coll Cardiol. 1994;23:1023-1030.
20. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103-2114.
21. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guide-lines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
22. Sial SH, Malone M, Freeman JL, Battiola R, Nachodsky J, Goodwin JS. Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction. J Gen Intern Med. 1994;9:599-605.
23. Pilote L, Califf RM, Sapp S, et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 1995;333:565-572.
24. Kennedy HL, Rosenson RS. Physician use of beta-adrenergic blocking therapy: a changing perspective. J Am Coll Cardiol. 1995;26:547-552.
25. Markson LE, Cosler LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med. 1994;154:1497-1504.
26. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease, I: treatments following myocardial infarction. JAMA. 1988;260:2088-2093.
27. Meehan TP, Hennen J, Radford MJ, Petrillo MK, Elstein P, Ballard DJ. Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project. Ann Intern Med. 1995;122:928-936.
28. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation. 1995;92:2841-2847.
29. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial. JAMA. 1993;270:1211-1216.
30. Kahn KL, Rogers WH, Rubenstein LV, et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. JAMA. 1990;264:1969-1973.
31. Shortell SM, Zimmerman JE, Rousseau DM, et al. The performance of intensive care units: does good management make a difference? Med Care. 1994;32:508-525.
32. Eisenberg JM. Are differences in outcome due to differences in doctors or their patients? Health Serv Res. 1995;30:291-294.
33. Iezzoni LI, Ash AS, Schwartz M, Daley J, Hughes JS, Mackiernan YD. Predicting who dies depends on how severity is measured: implications for evaluating patient outcomes. Ann Intern Med. 1995;123:763-770.
34. Elmore JG, Viscoli CM, Horwitz RI. The evolving clinical status of patients after a myocardial infarction: the importance of post-hospital data for mortality prediction. J Clin Epidemiol. 1996;49:1233-1238.
35. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
36. Gatsonis CA, Epstein AM, Newhouse JP, Normand SL, McNeil BJ. Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction: an analysis using hierarchical logistic regression. Med Care. 1995;33:625-642.